These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Noninvasive paternal exclusion testing for cystic fibrosis in the first five to eight weeks of gestation. Zeevi DA; Zahdeh F; Kling Y; Rosen T; Renbaum P; Ron-El R; Eldar-Geva T; Holzer HEG; Levy-Lahad E; Altarescu G Sci Rep; 2018 Oct; 8(1):15941. PubMed ID: 30374031 [TBL] [Abstract][Full Text] [Related]
10. Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Variants in Individuals Evaluated for Primary Ciliary Dyskinesia. Hannah WB; Truty R; Gonzales V; Kithcart GP; Ouyang K; Zeman MK; Li C; Drumm M; Nykamp K; Gaston BM J Pediatr; 2019 Dec; 215():172-177.e2. PubMed ID: 31610925 [TBL] [Abstract][Full Text] [Related]
11. Dynamic modification strategy of the Israeli prenatal carrier screening protocol: inclusion of the oriental Jewish group to the cystic fibrosis panel-update. Reish O; Shohat M; Magal N; Pesso R; Borochowitz ZU; Adir V; Karpati M; Shimshoni DC Genet Med; 2009 May; 11(5):372. PubMed ID: 19346956 [No Abstract] [Full Text] [Related]
12. Prenatal screening for cystic fibrosis: where are we now? Farrell PM; Fost N J Pediatr; 2002 Dec; 141(6):758-63. PubMed ID: 12461490 [No Abstract] [Full Text] [Related]
13. Carrier screening for cystic fibrosis. Dungan JS Obstet Gynecol Clin North Am; 2010 Mar; 37(1):47-59, Table of Contents. PubMed ID: 20494257 [TBL] [Abstract][Full Text] [Related]
14. A Cross-Sectional Study of the Marital Attitudes of Pregnant Women at Risk for Cystic Fibrosis and Psychological Impact of Prenatal Screening. Popa ZL; Margan MM; Petre I; Bernad E; Stelea L; Chiriac VD; Craina M; Ciuca IM; Bina AM Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886548 [TBL] [Abstract][Full Text] [Related]
16. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene. Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181 [TBL] [Abstract][Full Text] [Related]
18. Assessing the Disease-Liability of Mutations in CFTR. Ferec C; Cutting GR Cold Spring Harb Perspect Med; 2012 Dec; 2(12):a009480. PubMed ID: 23209179 [TBL] [Abstract][Full Text] [Related]
19. Assessment of CFTR function in native epithelia for the diagnosis of cystic fibrosis. Barreto C; Mall M; Amaral MD Pediatr Pulmonol Suppl; 2004; 26():243. PubMed ID: 15029663 [No Abstract] [Full Text] [Related]
20. Cystic fibrosis gene testing a challenge: experts say widespread use is creating unnecessary risks. Vastag B JAMA; 2003 Jun; 289(22):2923-4. PubMed ID: 12799389 [No Abstract] [Full Text] [Related] [Next] [New Search]